The development of targeted neurobiological therapies in child and adolescent psychiatry

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 52, Issue 8, 2013, Pages 775-779

  Vitiello, Benedetto ^a   Grabb, Margaret ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; ACAMPROSATE; BACLOFEN; BUTYRIC ACID; CARNITINE; CITALOPRAM; DEOXYCYTIDINE; FLUVOXAMINE; FRAGILE X MENTAL RETARDATION PROTEIN; METHYLPHENIDATE; PLACEBO; RISPERIDONE; RNA BINDING PROTEIN; VALPROIC ACID;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTISM; BIOLOGICAL THERAPY; CHILD PSYCHIATRY; CONTROLLED CLINICAL TRIAL (TOPIC); DEPRESSION; EMBRYO DEVELOPMENT; EXPERIMENTAL MEDICINE; FRAGILE X SYNDROME; GENE EXPRESSION; GILLES DE LA TOURETTE SYNDROME; HUMAN; INTELLECTUAL IMPAIRMENT; METHYLATION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; TRANSCRANIAL MAGNETIC STIMULATION; X CHROMOSOME;

EID: 84880581609     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1016/j.jaac.2013.06.002     Document Type: Editorial

References (23)

1. C. Bagni, F. Tassone, G. Neri, and R. Hagerman Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics J Clin Invest 122 2012 4314 4322
2. L.S. Wijetunge, Chattarji, D.J.A. Wyllie, and P.C. Kind Fragile X syndrome: from targets to treatment Neuropharmacology 68 2013 83 96
3. E. Berry-Kravis, D. Hessl, and S. Coffey A pilot open label, single dose trial of fenobam in adults with fragile X syndrome J Med Genet 46 2009 266 271
4. C.A. Erickson, L.K. Wink, and B. Ray Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome Psychopharmacology (Berl) 228 2013 75 84
5. J.C. Darnell, and E. Klann The translation of translational control by FMRP: therapeutic targets for FXS Nat Neurosci 16 2013 1 7
6. The MTA Cooperative Group A 14-Month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder (ADHD) Arch Gen Psychiatry 56 1999 1073 1086
7. Research Units on Pediatric Psychopharmacology Anxiety Study Group Fluvoxamine for the treatment of anxiety disorders in children and adolescents N Engl J Med 344 2001 1279 1285
8. Research Units on Pediatric Psychopharmacology Autism Network Risperidone in children with autism and serious behavioral problems N Engl J Med 347 2002 314 321 55
9. Treatment for Adolescents with Depression Study (TADS) Team Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression JAMA 292 2004 807 820
10. The Pediatric OCD Treatment Study (POTS) Team Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder JAMA 292 2004 1969 1976
11. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network A randomized controlled crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity Arch Gen Psychiatry 62 2005 1266 1274
12. L. Greenhill, S. Kollins, and H. Abikoff Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD J Am Acad Child Adolesc Psychiatry 45 2006 1284 1293
13. D. Brent, G. Emslie, and G. Clarke The Treatment of Adolescents with SSRI-Resistant Depression (TORDIA): a comparison of switch to venlafaxine or to another SSRI, with or without additional cognitive behavioral therapy JAMA 299 2008 901 913
14. L. Sikich, J.A. Frazier, and J. McClellan Double-blind comparison of antipsychotics in early onset schizophrenia and schizoaffective disorder Am J Psychiatry 165 2008 1420 1431
15. J.T. Walkup, A.M. Albano, and J. Piacentini Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety N Engl J Med 359 2008 2753 2766
16. J. Garber, G.N. Clarke, and V.N. Weersing Prevention of depression in at-risk adolescents JAMA 301 2009 2215 2224
17. M.G. Aman, C.J. McDougle, and L. Scahill Medication and parent training in children with pervasive developmental disorders and serious behavior problems J Am Acad Child Adolesc Psychiatry 48 2009 1143 1154
18. B.H. King, E. Hollander, and L. Sikich Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism Arch Gen Psychiatry 66 2009 583 590
19. B. Geller, J.L. Luby, and P. Joshi A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents Arch Gen Psychiatry 51 2012 867 878
20. T. Insel, B. Cuthbert, and M. Garvey Research domain criteria (RDoC): toward a new classification framework for research on mental disorders Am J Psychiatry 167 2010 748 751
21. K. Le, L. Liu, M. Sun, L. Hu, and N. Xiao Transcranial magnetic stimulation at 1 Hertz improves clinical symptoms in children with Tourette syndrome for at least 6 months J Clin Neurosci 20 2013 257 262
22. G. Mayer, S. Aviram, G. Walter, Y. Levkovitz, and Y. Bloch Long-term follow-up of adolescents with resistant depression treated with repetitive transcranial magnetic stimulation J ECT 28 2012 84 86
23. National Institute on Mental Health New Experimental Medicine Studies: Fast-Fail Trials in Autism Spectrum Disorders (FAST-AS) Solicitation number: HHS-NIH-DA-12-241 2012 Department of Health and Human Services, National Institutes of Health Bethesda, MD